How does cannabis slow down the development of Alzheimer's disease?

Collected research on TruthOnPot.com indicates a large role of cannabis in slowing the progression of Alzheimer's disease.

Researchers at the Roskamp Institute in Florida have shown for the first time how cannabinoids – active substances contained in CBD oils and CBD pastes – are able to reduce the accumulation of key indicators of Alzheimer's disease.

For a long time, the researchers linked the loss of cells and then brain tissue characteristic of Alzheimer's to abnormal structures called beta-amyloid (A) plaques. The levels of plaques in the patient's brain allow to determine the severity of symptoms and tissue damage.

A scientific study published in early July in the Molecular and Cellular Neuroscience Journal shows how cannabinoids (CBD) reverse the accumulation of beta-amyloid plaque by removing it from the brain.

CBD oil action

A group led by Dr. Corbin Bachmeier explains that Alzheimer's disease is not the result of abnormal plaque production but of impaired A purification from the brain. The results clearly suggest that the chemical compounds contained in marijuana may support the crossing of the blood-brain barrier by plaques A - a process that allows to maintain low levels of plaques in healthy people. Previous studies have shown that this process is blocked in Alzheimer's patients. While this study is the first to identify the unique functions of cannabinoids (CBD), it confirms the results of previous studies linking cannabinoids to reducing plaque levels and Alzheimer's symptoms.

Other researchers have also suggested that cannabinoids cause a variety of effects that may be helpful in treating this condition. Earlier this year, senior researcher at the Australian Institute of Neurobiology Dr Tim Karl, who was not involved in the study described above, found that mice with Alzheimer's experience dramatic improvements in memory after dosing cannabidiol (CBD). CBD is one of more than 60 cannabinoids contained in marijuana that particularly catches the attention of scientists due to the lack of psychoactive effects (unlike THC).

Previous research points to the anti-inflammatory properties of cannabinoids, which are equally useful in Alzheimer's disease.

Alzheimer's CBD

Dr. Gary Wenk, a professor of neurobiology, immunology and medical genetics at Ohio State University, was one of the first researchers to suggest this. For more than 25 years, I have been trying to find a drug that will reduce inflammation of the brain and restore cognitive abilities in rats; cannabinoids are the first group of drugs that have ever been effective. told Time Magazine. Dr. Wenk believes that stigma still hinders wide acceptance of cannabis-based drugs, but he is hopeful that this will change in the coming years.

Alzheimer's disease is at the forefront of disability among a growing senior population. Without breakthrough treatment, the number of Alzhaimer cases is expected to triple over the next 50 years.

SOURCE: THE RESEARCH WAS PUBLISHED ON 3 JULY 2013 AND FUNDED BY THE INDEPENDENT NON-PROFIT RESEARCH FOUNDATION – ROSKAMP INSTITUTE,